6NB9 image
Deposition Date 2018-12-06
Release Date 2019-08-07
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6NB9
Keywords:
Title:
Amyloid-Beta (20-34) with L-isoaspartate 23
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.05 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Amyloid-beta A4 protein
Gene (Uniprot):APP
Mutations:L-isoaspartate 23
Chain IDs:A
Chain Length:15
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structure of amyloid-beta (20-34) with Alzheimer's-associated isomerization at Asp23 reveals a distinct protofilament interface.
Nat Commun 10 3357 3357 (2019)
PMID: 31350392 DOI: 10.1038/s41467-019-11183-z

Abstact

Amyloid-β (Aβ) harbors numerous posttranslational modifications (PTMs) that may affect Alzheimer's disease (AD) pathogenesis. Here we present the 1.1 Å resolution MicroED structure of an Aβ 20-34 fibril with and without the disease-associated PTM, L-isoaspartate, at position 23 (L-isoAsp23). Both wild-type and L-isoAsp23 protofilaments adopt β-helix-like folds with tightly packed cores, resembling the cores of full-length fibrillar Aβ structures, and both self-associate through two distinct interfaces. One of these is a unique Aβ interface strengthened by the isoaspartyl modification. Powder diffraction patterns suggest a similar structure may be adopted by protofilaments of an analogous segment containing the heritable Iowa mutation, Asp23Asn. Consistent with its early onset phenotype in patients, Asp23Asn accelerates aggregation of Aβ 20-34, as does the L-isoAsp23 modification. These structures suggest that the enhanced amyloidogenicity of the modified Aβ segments may also reduce the concentration required to achieve nucleation and therefore help spur the pathogenesis of AD.

Legend

Protein

Chemical

Disease

Primary Citation of related structures